OSI Pharmaceuticals, Inc. (NASDAQ: OSIP) will present fourth quarter and year end Tarceva (erlotinib) sales today during the Company's presentation ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE